Gland Pharma Limited IPO – GMP, Review, Share Price, Subscription, and Details

1.Gland Pharma Limited IPO Overview

The initial public offering (IPO) of Gland Pharma Limited is a public issue under the Mainboard board. The subscription window is scheduled to open on Nov 9, 2020 and close on Nov 11, 2020, with the price band fixed at ₹1490–1500 per equity share.

2.Issue Details at a Glance

3.Bidding, Allotment & Listing Timeline

• Bidding opens: Nov 9, 2020
• Bidding closes: Nov 11, 2020
• Allotment date: TBA
• Listing date: 2020-11-20
• Minimum investment: ₹14,900 for 10 shares
• Official document: Download Gland Pharma Limited RHP PDF

4.Gland Pharma Limited IPO GMP Today

No grey market premium has been recorded for Gland Pharma Limited yet. GMP is an informal, unregulated indicator of listing-day sentiment and is not published by any exchange.

5.How to Apply for Gland Pharma Limited IPO

1. 1Open IPOGMPTracker or use your broker's app or net banking ASBA facility.
2. 2Search for "Gland Pharma Limited IPO" and select it from the list of current issues.
3. 3Choose your demat account and enter your bid quantity in multiples of the 10-share lot, at a price within the ₹1490–1500 band (or bid at cut-off, if eligible).
4. 4Submit the application and approve the UPI mandate request when it arrives — funds stay blocked in your account and are debited only on allotment.

Allotment is expected to be finalised around TBA, with listing tentatively scheduled for 2020-11-20 on BSE and NSE. Once finalised, check your status on the Gland Pharma Limited IPO allotment status page.

6.How to Track Subscription & Allotment

• Live subscription: Track QIB, NII and retail bidding on the IPO subscription status page
• Allotment status: Check your application on the IPO allotment status page
• Full IPO details: See dates, lot size, reservation and financials on the Gland Pharma Limited IPO page
• More issues: Browse current IPOs, upcoming IPOs and the IPO event calendar

7.Conclusion

Gland Pharma Limited opens on Nov 9, 2020 and closes on Nov 11, 2020 at ₹1490–1500 per share. Read the offer documents in full and consult a qualified adviser before applying — nothing on this page is investment advice.